Latest Insider Transactions at Alkermes Plc. (ALKS)
This section provides a real-time view of insider transactions for Alkermes Plc. (ALKS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alkermes plc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alkermes plc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,647
-37.29%
|
$169,410
$30.6 P/Share
|
|
Sep 14
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,143
+50.0%
|
-
|
|
Sep 14
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,024
-2.7%
|
$60,720
$30.6 P/Share
|
|
Sep 14
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,884
+8.4%
|
-
|
|
Sep 14
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,566
-1.59%
|
$106,980
$30.6 P/Share
|
|
Sep 14
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
8,031
+3.45%
|
-
|
|
Sep 14
2021
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,608
-19.91%
|
$138,240
$30.6 P/Share
|
|
Sep 14
2021
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,672
+40.37%
|
-
|
|
Sep 14
2021
|
Richard F Pops Director and CEO, Alkermes plc |
SELL
Payment of exercise price or tax liability
|
Direct |
36,267
-4.15%
|
$1,088,010
$30.6 P/Share
|
|
Sep 14
2021
|
Richard F Pops Director and CEO, Alkermes plc |
BUY
Grant, award, or other acquisition
|
Direct |
81,682
+8.55%
|
-
|
|
Aug 23
2021
|
Emily Peterson Alva Director |
BUY
Open market or private purchase
|
Direct |
1,650
+50.0%
|
$49,500
$30.22 P/Share
|
|
Aug 19
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
40,000
-48.2%
|
$1,160,000
$29.99 P/Share
|
|
Aug 19
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+32.53%
|
$640,000
$16.55 P/Share
|
|
Aug 02
2021
|
Brian P Mckeon Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$260,000
$26.43 P/Share
|
|
Jul 29
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Open market or private sale
|
Direct |
14,000
-15.8%
|
$364,000
$26.0 P/Share
|
|
Jul 29
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+13.65%
|
$224,000
$16.55 P/Share
|
|
Jul 01
2021
|
David W Anstice Director |
SELL
Open market or private sale
|
Direct |
20,000
-21.49%
|
$480,000
$24.58 P/Share
|
|
Jul 01
2021
|
David W Anstice Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+17.69%
|
$280,000
$14.6 P/Share
|
|
Jun 10
2021
|
Wendy L Dixon Director |
SELL
Open market or private sale
|
Direct |
25,000
-37.71%
|
$625,000
$25.0 P/Share
|
|
Jun 10
2021
|
Wendy L Dixon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+27.38%
|
$450,000
$18.21 P/Share
|
|
Jun 10
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Open market or private sale
|
Direct |
13,500
-15.32%
|
$337,500
$25.0 P/Share
|
|
Jun 10
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
13,500
+13.29%
|
$216,000
$16.55 P/Share
|
|
Jun 09
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
882
-100.0%
|
$21,168
$24.6 P/Share
|
|
Jun 07
2021
|
David W Anstice Director |
SELL
Open market or private sale
|
Direct |
5,000
-6.4%
|
$120,000
$24.0 P/Share
|
|
Jun 07
2021
|
David W Anstice Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.02%
|
$70,000
$14.6 P/Share
|
|
Jun 07
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Open market or private sale
|
Direct |
13,500
-15.32%
|
$324,000
$24.0 P/Share
|
|
Jun 07
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
13,500
+13.29%
|
$216,000
$16.55 P/Share
|
|
Jun 07
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-29.44%
|
$8,464
$23.5 P/Share
|
|
Jun 07
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+50.0%
|
-
|
|
Jun 05
2021
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,029
-12.1%
|
$23,667
$23.08 P/Share
|
|
Jun 05
2021
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+29.16%
|
-
|
|
May 20
2021
|
David W Anstice Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,404
-1.88%
|
$29,484
$21.92 P/Share
|
|
May 20
2021
|
David W Anstice Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+7.57%
|
-
|
|
May 20
2021
|
Robert A Breyer Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,930
-22.1%
|
$61,530
$21.92 P/Share
|
|
May 20
2021
|
Robert A Breyer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+31.52%
|
-
|
|
May 20
2021
|
Shane Cooke Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,175
-3.49%
|
$66,675
$21.92 P/Share
|
|
May 20
2021
|
Shane Cooke Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+6.29%
|
-
|
|
May 20
2021
|
Wendy L Dixon Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,404
-3.29%
|
$29,484
$21.92 P/Share
|
|
May 20
2021
|
Wendy L Dixon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+12.51%
|
-
|
|
May 20
2021
|
Richard Gaynor Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,404
-23.0%
|
$29,484
$21.92 P/Share
|
|
May 20
2021
|
Richard Gaynor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+50.0%
|
-
|
|
May 20
2021
|
Paul J Mitchell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,930
-20.77%
|
$61,530
$21.92 P/Share
|
|
May 20
2021
|
Paul J Mitchell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+30.21%
|
-
|
|
May 20
2021
|
Nancy Lynn Md Snyderman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,404
-23.0%
|
$29,484
$21.92 P/Share
|
|
May 20
2021
|
Nancy Lynn Md Snyderman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+50.0%
|
-
|
|
May 20
2021
|
Frank Anders Wilson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,404
-23.0%
|
$29,484
$21.92 P/Share
|
|
May 20
2021
|
Frank Anders Wilson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+50.0%
|
-
|
|
May 20
2021
|
Nancy Wysenski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,404
-23.0%
|
$29,484
$21.92 P/Share
|
|
May 20
2021
|
Nancy Wysenski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+50.0%
|
-
|
|
May 18
2021
|
Richard F Pops Director and CEO, Alkermes plc |
SELL
Open market or private sale
|
Direct |
150,000
-15.92%
|
$3,150,000
$21.9 P/Share
|